This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the MetALD definition in practice, and its impact on classification, guidelines, drug development, and patient care.

With Thomas Marjot (Host), Mary Rinella (Faculty) and Aleksander Krag (Faculty).

Talk Liver To Me is supported by Boehringer Ingelheim, GSK, IPSEN and Opella. Sponsors have had no input to the content of this programme.